0000950170-24-001035.txt : 20240103 0000950170-24-001035.hdr.sgml : 20240103 20240103165423 ACCESSION NUMBER: 0000950170-24-001035 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231229 FILED AS OF DATE: 20240103 DATE AS OF CHANGE: 20240103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: PALEKAR ROHAN CENTRAL INDEX KEY: 0001423327 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39122 FILM NUMBER: 24507711 MAIL ADDRESS: STREET 1: 201 SPEAR STREET, THIRD FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94105 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: 89bio, Inc. CENTRAL INDEX KEY: 0001785173 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 831114349 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 142 SANSOME STREET STREET 2: SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: (415) 432-9270 MAIL ADDRESS: STREET 1: 142 SANSOME STREET STREET 2: SECOND FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 4 1 ownership.xml 4 X0508 4 2023-12-29 0001785173 89bio, Inc. ETNB 0001423327 PALEKAR ROHAN C/O 89BIO, INC. 142 SANSOME STREET, 2ND FLOOR SAN FRANCISCO CA 94104 true true false false Chief Executive Officer true Common Stock 2023-12-29 4 M false 50000 1.93 A 351225 D Common Stock 2023-12-29 4 S false 50000 11.20 D 301225 D Stock Option (Right to Buy) 1.93 2023-12-29 4 M false 50000 0.00 D 2028-11-09 Common Stock 50000 145231 D Includes an aggregate of 275 shares acquired by the Reporting Person under the Issuer's 2019 Employee Stock Purchase Plan on December 31, 2023. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on July 5, 2023. The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $11.035 to $11.33. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. This option is vested in full. /s/ Ryan A. Murr, as attorney-in-fact for Rohan Palekar 2024-01-03